Clinical Trial Update: A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07) [Phase 3]

View source ↗

Summary

This Phase 3 trial (PANKU-Lung07) compares BL-B01D1 plus tislelizumab versus platinum-containing chemotherapy plus tislelizumab as first-line treatment in exten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• BL-B01D1
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 3 | Status: NOT_YET_RECRUITING